These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 23233738)
21. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Dasgupta S; Menezes ME; Das SK; Emdad L; Janjic A; Bhatia S; Mukhopadhyay ND; Shao C; Sarkar D; Fisher PB Clin Cancer Res; 2013 Sep; 19(17):4621-33. PubMed ID: 23873690 [TBL] [Abstract][Full Text] [Related]
22. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis. Maji S; Pradhan AK; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Windle JJ; Subler MA; Wang XY; Semmes OJ; Nyalwidhe JO; Mukhopadhyay N; Paul AK; Hatfield B; Levit MM; Madan E; Sarkar D; Emdad L; Cohen DJ; Gogna R; Cavenee WK; Das SK; Fisher PB Proc Natl Acad Sci U S A; 2023 Nov; 120(45):e2307094120. PubMed ID: 37922327 [TBL] [Abstract][Full Text] [Related]
23. Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells. Kim O; Hwangbo C; Tran PT; Lee JH Cell Death Dis; 2022 Feb; 13(2):122. PubMed ID: 35136055 [TBL] [Abstract][Full Text] [Related]
24. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536 [TBL] [Abstract][Full Text] [Related]
25. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma. Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033 [TBL] [Abstract][Full Text] [Related]
26. Expression patterns of MDA-9/syntenin during development of the mouse embryo. Jeon HY; Das SK; Dasgupta S; Emdad L; Sarkar D; Kim SH; Lee SG; Fisher PB J Mol Histol; 2013 Apr; 44(2):159-66. PubMed ID: 23180153 [TBL] [Abstract][Full Text] [Related]
27. mda-9/Syntenin protein positively regulates the activation of Akt protein by facilitating integrin-linked kinase adaptor function during adhesion to type I collagen. Hwangbo C; Park J; Lee JH J Biol Chem; 2011 Sep; 286(38):33601-12. PubMed ID: 21828040 [TBL] [Abstract][Full Text] [Related]
28. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer. Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394 [TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis. Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015 [TBL] [Abstract][Full Text] [Related]
30. MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif. Okumura F; Yoshida K; Liang F; Hatakeyama S Mol Cell Biochem; 2011 Jun; 352(1-2):163-72. PubMed ID: 21359963 [TBL] [Abstract][Full Text] [Related]
32. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis. Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681 [TBL] [Abstract][Full Text] [Related]
33. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis. Das SK; Maji S; Wechman SL; Bhoopathi P; Pradhan AK; Talukdar S; Sarkar D; Landry J; Guo C; Wang XY; Cavenee WK; Emdad L; Fisher PB Pharmacol Res; 2020 May; 155():104695. PubMed ID: 32061839 [TBL] [Abstract][Full Text] [Related]
34. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis. Yang JB; McCarthy JB Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924 [TBL] [Abstract][Full Text] [Related]
35. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. Stoeltzing O; McCarty MF; Wey JS; Fan F; Liu W; Belcheva A; Bucana CD; Semenza GL; Ellis LM J Natl Cancer Inst; 2004 Jun; 96(12):946-56. PubMed ID: 15199114 [TBL] [Abstract][Full Text] [Related]
36. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma. Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040 [TBL] [Abstract][Full Text] [Related]
37. MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin. Tian W; Wu W; Li X; Rui X; Wu Y Biochem Biophys Res Commun; 2019 Jan; 508(1):295-301. PubMed ID: 30502089 [TBL] [Abstract][Full Text] [Related]
38. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950 [TBL] [Abstract][Full Text] [Related]
39. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation. Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602 [TBL] [Abstract][Full Text] [Related]
40. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]